Dipeptidyl Peptidase - 4 Inhibitors - An Overview of the Combination of These Molecules and Hypoglicemic Oral Drugs

The purpose of the current review is to bring up date some studies and data about effects hypoglycemic oral drugs in combination with DPP-4 inhibitors. As medicine pharmaceutical industry are revolutionary type 2 diabetes protocols, scientists made a close research on patients that have combined metformin plus sulfonyurea Statistics showed sulfonylurea compared inhibitors, metformin, increased risk severe hypoglycemia, fatal nonfatal cardiovascular diseases, mortality. Another important discovery insulin associated all-caused mortality, inhibitors metformin.